$BCLI 4/A SEC Filings

Filed On	Filing
31 Jul 2024	Form 4/A: Lebovits Chaim, President & CEO Bought 15,000 shares ($7.77K)
31 Jul 2024	Form 4/A: Lebovits Chaim, President & CEO Bought 25,000 shares ($14.5K) · Bought 25,000 shares ($16K)
31 Jul 2024	Form 4/A: Lebovits Chaim, President & CEO Bought 20,000 shares ($9.3K) · Bought 10,000 shares ($4.67K) · Bought 10,000 shares ($4.9K)
31 Jul 2024	Form 4/A: Lebovits Chaim, President & CEO Bought 66,300 shares ($24.8K)
31 Jul 2024	Form 4/A: Lebovits Chaim, President & CEO Bought 135,000 shares ($50.7K)
31 Jul 2024	Form 4/A: Lebovits Chaim, President & CEO Bought 15,000 shares ($7.8K)
31 Jul 2024	Form 4/A: Lebovits Chaim, President & CEO Bought 130,000 shares ($70.9K) · Bought 115,072 shares ($60.5K)
20 Mar 2018	Form 4/A: Almenoff June Sherie, Director Bought 5,700 shares ($20K)
20 Mar 2018	Form 4/A: Kern Ralph Dr., COO and Chief Medical Officer Bought 5,000 shares ($18K)
13 Oct 2015	Form 4/A: Lebovits Chaim, See Remarks Granted 369,619 Stock Option (right to buy)
27 Aug 2012	Form 4/A: Sossover Liat, Chief Financial Officer Granted 60,000 Stock Option (right to buy)
27 Aug 2012	Form 4/A: Harel Adrian, Chief Executive Officer Granted 70,000 Stock Option (right to buy)
16 Nov 2011	Form 4/A: Schor Chen, Director Received 923,374 shares as a grant or award
29 Apr 2011	Form 4/A: Taub Malcolm S, Director Holds 0 Stock Option (right to buy) (exercise price $0.00)
09 Mar 2009	Form 4/A: Javitt Jonathan C, Director Holds 0 Warrant to Purchase Common Stock (exercise price $0.00)
05 Mar 2009	Form 4/A: Javitt Jonathan C, Director Acquired 0 shares (Other Transaction)
26 Mar 2007	Form 4/A: Greenfield Michael D, Director Received 100,000 shares as a grant or award

Comments